As of 01 December 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of (1) Atezolizumab [60 mg/mL, 20 mL vial for intravenous (IV) infusion] + Bevacizumab [25 mg/mL, 4 mL or 16 mL vial for IV infusion] and (2) Lenvatinib [4 mg/10 mg capsule] for adults diagnosed with advanced continue reading : HTA Council Preliminary Recommendation on (1) Atezolizumab + Bevacizumab and (2) Lenvatinib for Adults Diagnosed with Advanced or Unresectable Hepatocellular Cancer (HCC)
HTA Council Preliminary Recommendation on Thermal Ablation for the Treatment of Premalignant Lesions of the Cervix among Women 30 to 65 years old
As of 19 November 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of Thermal Ablation for the treatment of premalignant lesions of the cervix among women 30 to 65 years old who are deemed eligible for ablation in accordance to the World Health Organization (WHO) screen-treat approach or screen-triage-treat continue reading : HTA Council Preliminary Recommendation on Thermal Ablation for the Treatment of Premalignant Lesions of the Cervix among Women 30 to 65 years old
HTA Division Citizen’s Charter
Issuance under the Department of Science and Technology (DOST) Office of the Secretary (OSEC) Citizens’ Charter The DOST HTA Division is committed to transparent and efficient service delivery in support of evidence-based health policy decisions. The HTA Division Citizens’ Charter (CC), issued under the DOST-OSEC Citizens’ Charter, outlines the Division’s key services, including: (1) Topic continue reading : HTA Division Citizen’s Charter
CALL FOR EXPRESSION OF INTEREST: HTA Research Agenda Program [HTA Research Topics 2025 – Batch 1] [EXTENDED]
HTA Philippines EXTENDS this call for proposals until 18 November 2025 (Tuesday) Interested researchers shall submit requirements to htaresearch@dost.gov.ph. The Health Technology Assessment (HTA) Philippines invites interested researchers to express interest and submit capsule proposals under the 2025 HTA Topics – Batch 1 Call [HTA General Track – Cycle 1 and Cycle 2 Clinical assessments; Pre-Cycle 1, Cycle 1, continue reading : CALL FOR EXPRESSION OF INTEREST: HTA Research Agenda Program [HTA Research Topics 2025 – Batch 1] [EXTENDED]
The Secretary of Health (SOH) fully concurs with the HTA Council Final Recommendations for the Government Financing of 12 health technologies
On 11 August 2025, the Secretary of Health (SOH) fully concurs with the Health Technology Council recommendation on the government financing of the following health technologies, through the Department of Health (DOH) Department Circulars 2025-0338, 2025-0339, and 2025-0340: For the full details on the HTA Council Final Recommendation, such as considerations and evidence, please see continue reading : The Secretary of Health (SOH) fully concurs with the HTA Council Final Recommendations for the Government Financing of 12 health technologies